Rheumatoid Arthritis Clinical Trials in Chicago

Showing 681-700 of 1,857 trials

Intermediate Expanded Access Protocol CNMAu8.EAP04

NCT06408727

An Intermediate Expanded Access Protocol (EAP) with CNM-Au8 for Amyotrophic Lateral Sclerosis for NIH Grant RFA-NS-23-012

ALSAmyotrophic Lateral SclerosisPALS

Clene Nanomedicine

Fort Lauderdale, Florida, United States • Chicago, Illinois, United States • Chicago, Illinois, United States +5 more locations

AVAILABLE2.2 miles

Intermediate-Size Expanded Access Protocol (EAP) for LP352

NCT06149663

This is an intermediate-size expanded access program (EAP) study. The purpose of this EAP is to provide continued access to LP352, an investigational drug product being investigated in participants with DEEs. The EAP study will allow continued treatment with LP352 for eligible participants diagnosed with treatment resistant DEEs who successfully completed an LP352 Clinical Trial (Enrollment by Invitation) or an immediate family member who has the exact same gene mutation resulting in the same DEE epilepsy syndrome phenotype or a patient who previously participated in the lorcaserin EAP.

Dravet SyndromeLennox Gastaut SyndromeDevelopmental and Epileptic Encephalopathies

Longboard Pharmaceuticals

Downey, California, United States • Los Angeles, California, United States • San Francisco, California, United States +19 more locations

Intermediate Expanded Access Protocol CNMAu8.EAP04

Intermediate-Size Expanded Access Protocol (EAP) for LP352

Rheumatoid Arthritis Trials in Other Cities

Duvelisib Exposure to Enhance Immune Profiles of T Cells in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma, DEEP T CELLS Study

Saypha® VOLUME Lidocaine for Midface Augmentation

Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T

The WEB-IT Clinical Study

Trauma-Focused Intervention With Women Experiencing Homelessness

Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002)

International EXPAND Heart Pivotal Trial

Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Chimney EndoVascular Aneurysm Sealing Of New Expanded Indication

Study of Nerve Repair and Reconstruction Associated With Major Extremity Trauma

Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

A Post-Market Clinical Evaluation of the Treatment of Tibia Fractures With the T2 Alpha Tibia Nailing System

A Study of Acute Respiratory Infections in Global Outpatient Setting

Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles

Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)

Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors

Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

Other Conditions in Chicago